HBK Sorce Advisory LLC Boosts Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

HBK Sorce Advisory LLC boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,482 shares of the exchange traded fund’s stock after purchasing an additional 279 shares during the quarter. HBK Sorce Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $404,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $141,284,000. Proficio Capital Partners LLC increased its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after buying an additional 911,686 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth $55,529,000. Finally, Mirae Asset Securities USA Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $87.13 on Friday. The company’s fifty day moving average price is $90.06 and its 200-day moving average price is $94.86. The firm has a market capitalization of $5.75 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.